In line with these results, our data show a significant reduction of pancreatic cancer cell proliferation, as measured by BrdU incorporation, as well as impaired migration and transwell invasion of pancreatic cancer cells upon knockdown of BCL9L. The gene discussed is BCL9L; the disease is familial pancreatic carcinoma.